These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4630708)

  • 1. Tremor and involuntary movements in monkeys: effect of L-dopa and of a dopamine receptor stimulating agent.
    Goldstein M; Battista AF; Ohmoto T; Anagnoste B; Fuxe K
    Science; 1973 Feb; 179(4075):816-7. PubMed ID: 4630708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine: mediator of brain polysome disaggregation after L-dopa.
    Weiss BF; Munro HN; Ordonez LA; Wurtman RJ
    Science; 1972 Aug; 177(4049):613-6. PubMed ID: 4403139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486).
    Yahr MD; Duvoisin RC; Mendoza MR; Schear MJ; Barrett RE
    Trans Am Neurol Assoc; 1971; 96():55-8. PubMed ID: 5159129
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-induced relief of experimental tremor in monkeys.
    Goldstein M; Battista AF; Nakatani S; Anagnoste B
    Neurology; 1970 Nov; 20(11):89-95. PubMed ID: 4991252
    [No Abstract]   [Full Text] [Related]  

  • 5. [Brain amines and apomorphine-induced intraspecific aggressive behavior in the rat (author's transl)].
    Senault B
    Psychopharmacologia; 1974 Jan; 34(2):143-54. PubMed ID: 4274176
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of centrally acting drugs on tremor in monkeys with mesencephalic lesions.
    Goldstein M; Battista AF; Nakatani S; Anagnoste B
    Proc Natl Acad Sci U S A; 1969 Aug; 63(4):1113-6. PubMed ID: 4982245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ET495 and brain catecholamine mechanisms: evidence for stimulation of dopamine receptors.
    Corrodi H; Farnebo LO; Fuxe K; Hamberger B; Ungerstedt U
    Eur J Pharmacol; 1972 Nov; 20(2):195-204. PubMed ID: 4651208
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of dopa decarboxylation by RO4-4602, MK 485 and MK 486 in human liver homogenates.
    Vogel WH; Mahoney K; Hare TA
    Arch Int Pharmacodyn Ther; 1972; 198(1):85-93. PubMed ID: 4538242
    [No Abstract]   [Full Text] [Related]  

  • 9. 4,4,6-trimethyl-3,4-dihydropyrimidine-2-thiol, an effective inhibitor of dopamine-beta-hydroxylation in vivo.
    Porter CC; Torchiana ML
    Biochem Pharmacol; 1971 Jan; 20(1):183-91. PubMed ID: 4398314
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of L-dopa and methyldopa on growth of mammary cancers in rats.
    Quadri SK; Kledzik GS; Meites J
    Proc Soc Exp Biol Med; 1973 Mar; 142(3):759-61. PubMed ID: 4692007
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms for the efflux of [14C]DOPA and[14C]dopamine from the CSF of rhesus monkeys.
    Shaywitz BA; Gormley WT; Arnold EL; Back KC
    J Neurochem; 1972 Jul; 19(7):1639-48. PubMed ID: 4625364
    [No Abstract]   [Full Text] [Related]  

  • 12. Action of L- -methyldopa-hydrazine on the blood pressure of patients receiving levodopa.
    Calne DB; Petrie A; Rao S; Reid JL; Vakil SD
    Br J Pharmacol; 1972 Jan; 44(1):162-4. PubMed ID: 5015036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of Parkinson's disease with L-dopa alone or combined with Ro 4-4602].
    Barbeau A; Gillo-Joffroy L; Mars H; Arsenault A
    Rev Can Biol; 1972; 31():Suppl:169-74. PubMed ID: 5052323
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inhibitors of catecholamine biosynthesis (review of the literature)].
    Frantsuzova SB
    Farmakol Toksikol; 1973; 36(5):624-8. PubMed ID: 4150865
    [No Abstract]   [Full Text] [Related]  

  • 15. Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists.
    Sethy VH; VAN Woert MH
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):13-28. PubMed ID: 4847901
    [No Abstract]   [Full Text] [Related]  

  • 16. Production of involuntary movements by L-dopa in monkeys with tegmental lesions.
    Battista AF; Goldstein M; Ogawa M
    Exp Neurol; 1971 Dec; 33(3):566-75. PubMed ID: 5002323
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversible effect of L-dopa on tremor and catatonia induced by alpha-methyl-p-tyrosine.
    Bédard P; Larochelle L; Poirier LJ; Sourkes TL
    Can J Physiol Pharmacol; 1970 Jan; 48(1):82-4. PubMed ID: 4984213
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: Clinical studies of dopaminergic mechanisms.
    Chase TN
    Psychopharmacol Bull; 1974 Jul; 10(3):43-4. PubMed ID: 4419336
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of behavioral and cardiovascular effects of L-DOPA and 5-HTP in conscious dogs.
    Dunkley B; Sanghvi I; Friedman E; Gershion S
    Psychopharmacologia; 1972; 26(2):161-72. PubMed ID: 4262886
    [No Abstract]   [Full Text] [Related]  

  • 20. [Facilitation of the effects of L-DOPA by alpha-methyldopa].
    Uspenskiĭ AE; Korobov NV
    Biull Eksp Biol Med; 1976 Mar; 81(3):314-6. PubMed ID: 986203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.